Insmed Inc’s recent filing unveils that its Chair and CEO Lewis William unloaded Company’s shares for reported $0.75 million on Aug 04 ’25. In the deal valued at $109.81 per share,6,830 shares were sold. As a result of this transaction, Lewis William now holds 233,924 shares worth roughly $25.63 million.
Then, Flammer Martina M.D. sold 8,715 shares, generating $954,292 in total proceeds. Upon selling the shares at $109.50, the Chief Medical Officer now owns 83,111 shares.
Before that, Lewis William bought 6,830 shares. Insmed Inc shares valued at $749,801 were divested by the Officer at a price of $109.78 per share.
Jefferies initiated its Insmed Inc [INSM] rating to a Buy in a research note published on May 13, 2025; the price target was $105. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late February with a ‘”an Outperform”‘ rating. Truist began covering INSM with “Buy” recommendation on April 23, 2024. Wolfe Research started covering the stock on February 15, 2024. It rated INSM as “an Outperform”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock jump 0.23% to $109.55. Over the last five days, the stock has gained 0.79%. Insmed Inc shares have risen nearly 50.73% since the year began. Nevertheless, the stocks have risen 58.68% over the past one year.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-07-15, dropping by -1.96 million shares to a total of 9.69 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 11.65 million shares. There was a decline of -20.25%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 08, 2023 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $55 price target.
